Studies to determine if IL-2 can prevent relapses in post-transplant NHL and AML.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D012008:Recurrence; D012074:Remission Induction / Q000379:methods; D014916:Whole-Body Irradiation
D007376:Interleukin-2; D005047:Etoposide; D003520:Cyclophosphamide